ESTRO 2024 - Abstract Book

S2808

Interdisciplinary - Health economics & health services research

ESTRO 2024

Conclusion:

Radiotherapy contributes significantly to 5-year survival, being delivered to almost 40% of patients overall. However, in those tumour sites where RT is delivered to appreciable numbers of patients (>5%), the average rate of RT use was higher, at just over 50%. This emphasises the importance of RT. The comparatively high numbers of patients with haematological cancers who received RT (around a quarter) were notable. The high percentages of patients with most individial tumour types that are treated with RT show the need for multi-disciplinary teams including radiation oncologists, together with adequate modern treatment planning and delivery. The low numbers of patients with some tumour types who received RT implies that multi-disciplinary decision-making is available in these teams and that RT has value to these few patients.

This 50% figure for RT use in tumour sites where RT has a numerically significant role is important and is contrary to popular perception. It is critical for service planning and public health messaging.

Keywords: Radiotherapy, different tumours

References:

1. Mee T, Kirkby NF, Defourny NN, Kirkby KJ, Burnet NG. The use of radiotherapy, surgery and chemotherapy in the curative treatment of cancer: results from the FORTY (Favourable Outcomes from RadioTherapY) project. Brit J Radiol. 2023 Oct 9:20230334. doi: 10.1259/bjr.20230334.

1366

Digital Poster